title: Modulation of all-trans-retinoic acid administered on intermittent schedule by alpha-interferon 2a in a patient with AIDS-related Kaposi's sarcoma.
authors.forename: S
authors.initials: S
authors.lastname: Toma
authors.forename: I
authors.initials: I
authors.lastname: Iacona
authors.forename: R
authors.initials: R
authors.lastname: Palumbo
authors.forename: L
authors.initials: L
authors.lastname: Moresco
authors.forename: P
authors.initials: P
authors.lastname: Raffo
authors.forename: M B
authors.initials: MB
authors.lastname: Regazzi
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000209:etiology; D014212:Tretinoin / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D016898:Interferon-alpha; D014212:Tretinoin